Skip to main content
OpenTrials
Completed

NCT Number: NCT02877693

A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging

To assess the clinical performance of the St. Jude Medical™ MR Conditional ICD System in patients undergoing an elective thoracic MRI scan.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medanta-The Medicity, Gurgaon, Haryana, India

Loading trial locations.

About this study

This clinical investigation is a prospective, multicenter, Asian study. The study was designed with two (2) parts, however only the 1st part was completed. For the 1st part, patients were enrolled with a SJM MR Conditional ICD System approved for thoracic scan with 1.5 Tesla MRI scanning machines. The 2nd part-meant to enroll patients for thoracic scans with 3 Tesla MRI scanning machines-was not completed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is pectorally implanted with St. Jude Medical™ MR Conditional ICD System for at least 60 days
  • Subject is willing to undergo an elective MRI scan without sedation NOTE: Antianxiety agents (e.g. minor tranquilizers, etc.) may be used as long as the patient can communicate with site personnel during the MRI scan
  • Subject's ventricular bipolar capture threshold is stable < 2.5V @ 0.5ms
  • Subject's ventricular sensing is measurable (patient has underlying rhythm > 30bpm) and the sensing amplitude is stable > 4mV
  • Subject is able to provide informed consent for study participation (legal guardian or legally authorized representative is NOT acceptable)
  • Subject is willing and able to comply with the prescribed follow-up tests and procedures
  • Subject is not contraindicated for an MRI scan (per the MRI Screening Form)

Exclusion criteria

  • Subject is pacemaker dependent
  • Subject has a non SJM MRI compatible endocardial lead implanted or capped
  • Subject has another existing active implanted medical device, e.g., neurostimulator, infusion pump, etc. that has MR labeling that will not allow the MRI scans per this protocol to be completed.
  • Subject has a high voltage lead revision incidence < 60 days of the enrollment visit
  • Subject has other non-MRI compatible device or material implanted NOTE: MRI compatible knee replacements, hip replacements, stents, etc. may be included as long as the labeling of these devices allow MRI scans conducted per this protocol NOTE: MRI compatible mechanical, prosthetic, and bioprosthetic heart valves may be included as long as the labeling of these devices allow for MRI scans conducted per this protocol NOTE: Non-removable dental implants may be included
  • Subject has a lead extender, adaptor, or capped/abandoned lead
  • Subject is enrolled or intend to participate in a clinical drug and/or device study (investigational device, investigational drug, new indication for a device or drug or additional testing beyond standard of care procedures), which could confound the results of this trial as determined by SJM.
  • Subject is pregnant or planning to become pregnant during the duration of the subject's participation in the study
  • Subject has a life expectancy of less than 12 months due to any condition
  • Subject has exclusion criteria required by local law (e.g., age)

Treatment and study plan

Thoracic MRI Scan

Radiation

The ICD system will be exposed to MRI scan of thoracic region, where the radiofrequency (RF) component of the scan is maximized.

Primary outcomes

  1. Number of Participants With Freedom From MRI-scan Related Complications* Related to St. Jude Medical™ MR Conditional ICD System

    Time frame: from MRI scan visit to 1 month post-MRI scan visit

    *A complication is a serious adverse device effect (SADE) that requires an invasive intervention or leads to death.

    The primary endpoint analysis will be performed for each study phase separately.

Other outcomes

  1. The Average Specific Absorption Rate (SAR)

    Time frame: MRI scan visit

    The average Specific Absorption Rate (SAR) during the MRI scan

  2. Number of Participants With Freedom From MRI-scan Related Complications* Related to St. Jude Medical™ MR Conditional ICD System

    Time frame: from MRI scan visit to 1-month post MRI scan visit

    This proportion was calculated as the number of subjects who had high voltage leads with capture threshold increases of ≤ 0.5V @ 0.5 ms from pre MRI scan testing to 1-month post MRI scan testing divided by total number of subjects who had high voltage lead implanted, underwent an MRI scan and had both pre-MRI scan and 1-month post MRI scan capture threshold measurements available.

  3. Proportion of SJM High Voltage Lead Implanted With SJM MR Conditional ICD With Sensing Amplitude Decrease of ≤ 50% From Pre-MRI Scan Testing to 1 Month Post-MRI Scan Testing

    Time frame: from pre MRI scan to 1-month post MRI scan

    This proportion was calculated as the number of subjects who had high voltage leads with sensing amplitude decrease of ≤ 50% from pre MRI scan testing to 1 month post MRI scan testing divided by the total number of subjects who had high voltage lead implanted, underwent an MRI scan and had both pre MRI scan and 1 month post MRI scan sensing amplitudes available.

  4. The Peak Specific Absorption Rate (SAR) During the MRI Scan

    Time frame: MRI Scan Visit

    The peak Specific Absorption Rate (SAR) during the MRI scan

  5. The Mean MRI Visit Duration in the MRI Lab

    Time frame: MRI Visit

    The mean MRI visit duration in the MRI lab

  6. Total MRI Scan Duration in MRI Laboratory

    Time frame: MRI Visit

    Total MRI scan duration in MRI laboratory

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Acronym: ASIA MRI ICD

Important dates

Study start
2016
Primary completion
2020
Study completion
2020
First posted
Aug 24, 2016
Registry last updated
Dec 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.